{"disease":{"id":"new-diagnosed-angioimmunoblastic-t-cell-lymphoma","name":"new diagnosed angioimmunoblastic t cell lymphoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07168317","title":"Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of New Diagnosed AITL","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"The Affiliated Hospital of Xuzhou Medical University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}